**Acknowledgement**

We are grateful for funding by the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology of Japan for the long-term clinical trial of OT in patients with ASD (Registered identifier UMIN00007250 in Table 3).
